Given the characteristic phenotypes of FXS are mediated by the loss of FMRP and its downstream regulatory functions, protein expression was an important consideration for the inclusion of the FXS 3 cell line in the FXS- cohort in subsequent analysis. This evidence concerns the gene FMR1 and fragile X syndrome.